TPU-0037-C demonstrates antibiotic activity against gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). TPU-0037-C was isolated from an actinomycete strain and it is a novel lydicamycin congener. The antibiotic is closely related to the neuritogenetic compound BU-4514N.
